Premium
Bedside diagnosis of mitochondrial dysfunction in aneurysmal subarachnoid hemorrhage
Author(s) -
Jacobsen A.,
Nielsen T. H.,
Nilsson O.,
Schalén W.,
Nordström C. H.
Publication year - 2014
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/ane.12258
Subject(s) - subarachnoid hemorrhage , ischemia , medicine , neurointensive care , vasospasm , cerebral vasospasm , brain ischemia , anesthesia , cardiology , pathology
Objectives Aneurysmal subarachnoid hemorrhage ( SAH ) is frequently associated with delayed neurological deterioration ( DND ). Several studies have shown that DND is not always related to vasospasm and ischemia. Experimental and clinical studies have recently documented that it is possible to diagnose and separate cerebral ischemia and mitochondrial dysfunction bedside. The study explores whether cerebral biochemical variables in SAH patients most frequently exhibit a pattern indicating ischemia or mitochondrial dysfunction. Methods In 55 patients with severe SAH , intracerebral microdialysis was performed during neurocritical care with bedside analysis and display of glucose, pyruvate, lactate, glutamate, and glycerol. The biochemical patterns observed were compared to those previously described in animal studies of induced mitochondrial dysfunction as well as the pattern obtained in patients with recirculated cerebral infarcts. Results In 29 patients, the biochemical pattern indicated mitochondrial dysfunction while 10 patients showed a pattern of cerebral ischemia, six of which also exhibited periods of mitochondrial dysfunction. Mitochondrial dysfunction was observed during 5162 h. An ischemic pattern was obtained during 688 h. Four of the patients (40%) with biochemical signs of ischemia died at the neurosurgical department as compared with three patients (10%) in the group of mitochondrial dysfunction. Conclusions The study documents that mitochondrial dysfunction is a common cause of disturbed cerebral energy metabolism in patients with SAH . Mitochondrial dysfunction may increase tissue sensitivity to secondary adverse events such as vasospasm and decreased cerebral blood flow. The separation of ischemia and mitochondrial dysfunction bedside by utilizing microdialysis offers a possibility to evaluate new therapies.